ATLANTA, GA -- (MARKET WIRE) -- November 21, 2006 -- AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, announced today that Russell M. Medford, M.D., Ph.D., President and Chief Executive Officer, is scheduled to present a company overview and update at the Lazard Capital Markets Third Annual Life Sciences Conference on Tuesday, November 28, 2006, at 9:00 a.m. ET at The New York Palace Hotel in New York, NY.
